ABSTRACT
Background: Adolescent pregnancy may be associated with medical complications related to the biological immaturity of the mother, and adult primiparous mothers may present perinatal outcomes associated with pre-existing age-related chronic changes. Objective: To compare unfavorable perinatal outcomes in adolescent and adult primiparous women. Material and methods: Observational, cross-sectional, retrospective and analytical study. Records of adolescent women from 12-19 years and adult women from 20-40 years in their first pregnancy, with a gestation of more than 20 weeks, who entered the Obstetrics Area of a third level hospital for pregnancy resolution were included. Perinatal outcomes were compared using chi-squared, Fisher's exact test, or Mann-Whitney U test. Results: 220 records of primiparous women, 110 adolescents aged 18 (16-19) and 110 adults aged 24 (21-25) were included. Adolescent mothers presented as unfavorable perinatal outcomes newborns (NB) small-for-gestational-age (SGA): odds ratio (OR) 2.95 (95%CI 1.10-7.85), p = 0.04. Adult pregnant women presented more comorbidities (gestational hypertension [11.82 vs. 3.64%] and preeclampsia [10.91 vs. 4.55%], gestational diabetes [6.36 vs. 0.91%], [p = 0.006]) that were associated with prematurity (p = 0.018) and with hospitalization in the NB (p = 0.008). Conclusions: Adolescent mothers presented twice more SGA NB. Prematurity and hospitalization of the NB was associated with the presence of comorbidities in adult mothers.
Introducción: el embarazo en la adolescencia puede estar asociado a complicaciones médicas relacionadas con la inmadurez biológica de la madre y las madres primigestas adultas pueden presentar resultados perinatales asociados a alteraciones crónicas preexistentes relacionadas con la edad. Objetivo: comparar los resultados perinatales desfavorables en primigestas adolescentes y adultas. Material y métodos: estudio observacional, transversal, retrospectivo y analítico. Se incluyeron expedientes de mujeres adolescentes de 12-19 años de edad y mujeres adultas de 20-40 años primigestas, con gestación mayor de 20 semanas, que ingresaron al área de Obstetricia de un hospital de tercer nivel para resolución del embarazo. Los resultados perinatales se compararon con chi cuadrada, prueba exacta de Fisher o U de Mann-Whitney. Resultados: se incluyeron 220 expedientes de mujeres primigestas, 110 adolescentes de 18 (16-19) años y 110 adultas de 24 (21-25) años. Las madres adolescentes presentaron como resultados perinatales desfavorables a recién nacidos (RN) con peso bajo para edad gestacional (PBEG): razón de momios (RM) 2.95 (IC 95% 1.10-7.85), p = 0.04. Las embarazadas adultas presentaron más comorbilidades (hipertensión gestacional [11.82 frente a 3.64%] y preeclampsia [10.91 frente a 4.55%], diabetes gestacional [6.36 frente a 0.91%], [p = 0.006]) que se asociaron con prematurez (p = 0.018) y con la hospitalización en el RN (p = 0.008). Conclusiones: las madres adolescentes presentaron dos veces más RN con PBEG. La prematurez y la hospitalizacion del RN se asoció a la presencia de comorbilidades de las madres adultas.
Subject(s)
Pre-Eclampsia , Pregnancy in Adolescence , Pregnancy , Adult , Infant, Newborn , Female , Adolescent , Humans , Retrospective Studies , Cross-Sectional Studies , Infant, Premature , Fetal Growth Retardation , Pregnancy OutcomeABSTRACT
Low Apgar score is associated with increased risk of death in preterm or full-term infants. However, the use of Apgar score to assess extremely preterm (EP) infants is controversial. In this study, we characterized the distribution of Apgar scores in EP infants with gestational age between 25 and 27 weeks, and investigated the association of Apgar score with survival rate at discharge by analyzing the clinical data of the EP infants discharged between January 2008 and December 2017 from 26 neonatal intensive care units in Guangdong Province, China. A total of 1567 infants with gestational age of 26.84±0.79 weeks and birth weight of 951±169 grams were involved in our study. The Apgar score increased with gestational age from 25 to 27 weeks and with time from birth from 1 to 10 min. The survival rate increased with a higher Apgar score, but no significant difference was found for 1-min Apgar score and the survival rate between infants with 25 or 26 weeks of gestation or 5-min Apgar score in infants with 25 weeks of gestation. The Apgar score is associated with survival of EP infants.
ABSTRACT
OBJECTIVE: The objective of this study was to provide a systematic review and meta-analysis to quantify prognosis and identify factors associated with variations in reported mortality estimates among infants who were born at 22 weeks of gestation and provided proactive treatment (resuscitation and intensive care). DATA SOURCES: PubMed, Scopus, and Web of Science databases, with no language restrictions, were searched for articles published from January 2000 to February 2020. STUDY ELIGIBILITY CRITERIA: Reports on live-born infants who were delivered at 22 weeks of gestation and provided proactive care were included. The primary outcome was survival to hospital discharge; secondary outcomes included survival without major morbidity and survival without neurodevelopmental impairment. Because we expected differences across studies in the definitions for various morbidities, multiple definitions for composite outcomes of major morbidities were prespecified. Neurodevelopmental impairment was based on Bayley Scales of Infant Development II or III. Data extractions were performed independently, and outcomes agreed on a priori. STUDY APPRAISAL AND SYNTHESIS METHODS: Methodological quality was assessed using the Quality in Prognostic Studies tool. An adapted version of the Grading of Recommendations Assessment, Development and Evaluation approach for prognostic studies was used to evaluate confidence in overall estimates. Outcomes were assessed as prevalence and 95% confidence intervals. Variabilities across studies attributable to heterogeneity were estimated with the I2 statistic; publication bias was assessed with the Luis Furuya-Kanamori index. Data were pooled using the inverse variance heterogeneity model. RESULTS: Literature searches returned 21,952 articles, with 2034 considered in full; 31 studies of 2226 infants who were delivered at 22 weeks of gestation and provided proactive neonatal treatment were included. No articles were excluded for study design or risk of bias. The pooled prevalence of survival was 29.0% (95% confidence interval, 17.2-41.6; 31 studies, 2226 infants; I2=79.4%; Luis Furuya-Kanamori index=0.04). Survival among infants born to mothers receiving antenatal corticosteroids was twice the survival of infants born to mothers not receiving antenatal corticosteroids (39.0% vs 19.5%; P<.01). The overall prevalence of survival without major morbidity, using a definition that includes any bronchopulmonary dysplasia, was 11.0% (95% confidence interval, 8.0-14.3; 10 studies, 374 infants; I2=0%; Luis Furuya-Kanamori index=3.02). The overall rate of survival without moderate or severe impairment was 37.0% (95% confidence interval, 14.6-61.5; 5 studies, 39 infants; I2=45%; Luis Furuya-Kanamori index=-0.15). Based on the year of publication, survival rates increased between 2000 and 2020 (slope of the regression line=0.09; standard error=0.03; P<.01). Studies were highly diverse with regard to interventions and outcomes reported. CONCLUSION: The reported survival rates varied greatly among studies and were likely influenced by combining observational data from disparate sources, lack of individual patient-level data, and bias in the component studies from which the data were drawn. Therefore, pooled results should be interpreted with caution. To answer fundamental questions beyond the breadth of available data, multicenter, multidisciplinary collaborations, including alignment of important outcomes by stakeholders, are needed.